RNA interference targeting ANGPTL3 for triglyceride and cholesterol lowering: phase 1 basket trial cohorts
出版年份 2023 全文链接
标题
RNA interference targeting ANGPTL3 for triglyceride and cholesterol lowering: phase 1 basket trial cohorts
作者
关键词
-
出版物
NATURE MEDICINE
Volume 29, Issue 9, Pages 2216-2223
出版商
Springer Science and Business Media LLC
发表日期
2023-08-25
DOI
10.1038/s41591-023-02494-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effect of Vupanorsen on Non–High-Density Lipoprotein Cholesterol Levels in Statin-Treated Patients With Elevated Cholesterol: TRANSLATE-TIMI 70
- (2022) Brian A. Bergmark et al. CIRCULATION
- A novel nanobody-heavy chain antibody against Angiopoietin-like protein 3 reduces plasma lipids and relieves nonalcoholic fatty liver disease
- (2022) Xiaozhi Hu et al. JOURNAL OF NANOBIOTECHNOLOGY
- Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk
- (2022) Aruna Das Pradhan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Transcriptomic therapy for dyslipidemias utilizing nucleic acids targeted at ANGPTL3
- (2021) Gerald F Watts et al. Future Cardiology
- Role of angiopoietin-like protein 3 in sugar-induced dyslipidemia in rhesus macaques: suppression by fish oil or RNAi
- (2020) Andrew A. Butler et al. JOURNAL OF LIPID RESEARCH
- Angiopoietin-like protein 3 (ANGPTL3) governs LDL-cholesterol levels through endothelial lipase-dependent VLDL clearance
- (2020) Rene C. Adam et al. JOURNAL OF LIPID RESEARCH
- Targeting RNA With Antisense Oligonucleotides and Small Interfering RNA in Dyslipidemias
- (2020) Julius L. Katzmann et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Vupanorsen, an N-acetyl galactosamine-conjugated antisense drug to ANGPTL3 mRNA, lowers triglycerides and atherogenic lipoproteins in patients with diabetes, hepatic steatosis, and hypertriglyceridaemia
- (2020) Daniel Gaudet et al. EUROPEAN HEART JOURNAL
- Evinacumab for Homozygous Familial Hypercholesterolemia
- (2020) Frederick J. Raal et al. NEW ENGLAND JOURNAL OF MEDICINE
- New insights into angiopoietin-like proteins in lipid metabolism and cardiovascular disease risk
- (2019) Sander Kersten CURRENT OPINION IN LIPIDOLOGY
- Personalized Medicine for Dyslipidemias by RNA Interference-Mediated Reductions in Apolipoprotein C3 or Angiopoietin-Like Protein 3
- (2019) So C. Wong et al. Journal of Clinical Lipidology
- Inhibition of Angiopoietin-Like Protein 3 With a Monoclonal Antibody Reduces Triglycerides in Hypertriglyceridemia
- (2019) Zahid Ahmad et al. CIRCULATION
- Reduction in First and Total Ischemic Events With Icosapent Ethyl Across Baseline Triglyceride Tertiles
- (2019) Deepak L. Bhatt et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Clinical review on triglycerides
- (2019) Ulrich Laufs et al. EUROPEAN HEART JOURNAL
- Role of angiopoietin-like 3 (ANGPTL3) in regulating plasma level of low-density lipoprotein cholesterol
- (2018) Yu-Xin Xu et al. ATHEROSCLEROSIS
- ANGPTL3 Deficiency and Protection Against Coronary Artery Disease
- (2017) Nathan O. Stitziel et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Angiopoietin-like 3 in lipoprotein metabolism
- (2017) Sander Kersten Nature Reviews Endocrinology
- Cardiovascular and Metabolic Effects of ANGPTL3 Antisense Oligonucleotides
- (2017) Mark J. Graham et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease
- (2017) Frederick E. Dewey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Efficacy and Safety of Evolocumab in High-Risk Patients Receiving a Statin
- (2017) Robert P. Giugliano et al. JAMA Cardiology
- Association of noninvasive quantitative decline in liver fat content on MRI with histologic response in nonalcoholic steatohepatitis
- (2016) Janki Patel et al. Therapeutic Advances in Gastroenterology
- Global Overview of the Epidemiology of Atherosclerotic Cardiovascular Disease
- (2015) Simon Barquera et al. ARCHIVES OF MEDICAL RESEARCH
- ANGPTL3 blockade with a human monoclonal antibody reduces plasma lipids in dyslipidemic mice and monkeys
- (2015) Viktoria Gusarova et al. JOURNAL OF LIPID RESEARCH
- Clinical characteristics and plasma lipids in subjects with familial combined hypolipidemia: a pooled analysis
- (2013) Ilenia Minicocci et al. JOURNAL OF LIPID RESEARCH
- Exome Sequencing,ANGPTL3Mutations, and Familial Combined Hypolipidemia
- (2010) Kiran Musunuru et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started